Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1701862

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1701862

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033

PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global onychomycosis treatment market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of this fungal infection among adults and millennials due to the increased exposure to public swimming pools and the use of tight, contaminated, or soiled clothes, shoes, socks, etc., is primarily driving the market.

Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete's foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.

Onychomycosis Treatment Market Trends:

The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Disease Type:

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Candidal Onychomycosis
  • Others

Breakup by Treatment Type:

  • Laser Therapy
  • Photodynamic Therapy
  • Drug Treatment

Breakup by Drug Class:

  • Allylamine
  • Azole
  • Griseofulvin
  • Others

Breakup by Distribution Channel:

  • Hospitals and Clinics
  • Online Stores
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Key Questions Answered in This Report

  • 1.What was the size of the global onychomycosis treatment market in 2024?
  • 2.What is the expected growth rate of the global onychomycosis treatment market during 2025-2033?
  • 3.What are the key factors driving the global onychomycosis treatment market?
  • 4.What has been the impact of COVID-19 on the global onychomycosis treatment market?
  • 5.What is the breakup of the global onychomycosis treatment market based on the disease type?
  • 6.What is the breakup of the global onychomycosis treatment market based on the treatment type?
  • 7.What is the breakup of the global onychomycosis treatment market based on the distribution channel?
  • 8.What are the key regions in the global onychomycosis treatment market?
  • 9.Who are the key players/companies in the global onychomycosis treatment market?
Product Code: SR112025A4877

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Onychomycosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Type

  • 6.1 Distal Subungual Onychomycosis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Proximal Subungual Onychomycosis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 White Superficial Onychomycosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Candidal Onychomycosis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Laser Therapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Photodynamic Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Allylamine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Azole
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Griseofulvin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cipla Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dr. Reddy's Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Galderma SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlaxoSmithKline PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kaken Pharmaceutical Co. Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lumenis Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Moberg Pharma AB
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 The OTC Lab B.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
Product Code: SR112025A4877

List of Figures

  • Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2024
  • Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2024
  • Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2024
  • Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
  • Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
  • Table 8: Global: Onychomycosis Treatment Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!